NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins
Description
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux – CM/PHR/22/5732
Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
The rest of this notice
The tender documents, the buyer's named contact and the award history for this notice are free. Create an account to open the full record.
- Download the tender documents
- Contact the buyer directly
- See who won, and for how much
- Get alerts for tenders like this one
Free — no card, no trial clock.
Guides for bidders
New to public sector tendering? These short guides explain how the process works.